Company: DAWN
Filing Date: 2025-01-13
Form Type: 8-K
Source: 0001193125-25-005012
Chunk: 1

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-01-13
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01      Regulation FD Disclosure.  

On January 13, 2025, the Company also announced its 2025 upcoming priorities and milestones, including that the Company expects to complete enrollment in the pivotal Phase 3 FIREFLY-2clinical trial evaluating tovorafenib as a front-line therapy in patients aged up to 25 years in the first half of 2026 and that the first dose cohort (a single-patient accelerated titration cohort) in the Phase 1a portion of the DAY301 Phase 1a/b clinical trial was cleared in January 2025. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

As previously announced, on January 13, 2025, the Company will participate in the 43rd Annual J. P. Morgan Healthcare Conference (the “ JPM Conference”). A copy of the Company’s presentation materials for the JPM Conference is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

Also on January 13, 2025, the Company updated its corporate presentation in connection with its participation in the JPM Conference. A copy of the updated corporate presentation materials is attached hereto as Exhibit 99.3 and is incorporated herein by reference.

The information in this Current Report on Form8-K, including Exhibits 99.1, 99.2 and 99.3 to this report, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act”). The information contained in this Current Report on Form8-Kand in the accompanying Exhibits 99.1, 99.2 and 99.3 shall not be incorporated by reference into any other filing under the Exchange Act or under the Securities Act, except as shall be expressly set forth by specific reference in such filing.